DNTH
Dianthus Therapeutics, Inc. · Healthcare
CFO, CBO Ryan Savitz sold $904K of Dianthus Therapeutics, Inc.
Sold$903,600
$45.18Price
20,000Shares
−100%Stake
What DNTH did after the filing
- The stock from Mon, Dec 8 open, $44.60
- +18.3%
- S&P 500, same days
- +1.2%
Measured over 30 trading days, to the Jan 22 close.
Traded Thu, Dec 4. Filed Fri, Dec 5, 8:00 PM ET, after the close. Returns use the Dec 8 open and the Jan 22 close. Not investment advice.